Depressive Disorder, Major
-
Subject Areas on Research
-
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder.
-
A Step Toward Optimizing Treatment Schedules for Continuation ECT: Response to Rasmussen.
-
A Subgroup Analysis of the Impact of Vortioxetine on Functional Capacity, as Measured by UPSA, in Patients with Major Depressive Disorder and Subjective Cognitive Dysfunction.
-
A case of transient hallucination with ropinirole augmentation antidepressant in a patient with treatment-resistant depression: Is there differential effect of ropinirole dose on developing psychotic symptom?
-
A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression.
-
A comparison of pure and comorbid CD/ODD and depression.
-
A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder.
-
A conceptual introduction to cognitive remediation for memory deficits associated with right unilateral electroconvulsive therapy.
-
A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study).
-
A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
-
A family study of chronic post-traumatic stress disorder following rape trauma.
-
A fidelity measure for integrated management of depression in primary care.
-
A longitudinal examination of the psychoeducational, neurocognitive, and psychiatric functioning in children with 22q11.2 deletion syndrome.
-
A longitudinal study of differences in late- and early-onset geriatric depression: depressive symptoms and psychosocial, cognitive, and neurological functioning.
-
A manual-based intervention to address clinical crises and retain patients in the Treatment of Adolescents With Depression Study (TADS).
-
A multi-site randomized clinical trial to reduce suicidal ideation in suicidal adult outpatients with Major Depressive Disorder: Development of a methodology to enhance safety.
-
A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
-
A repeated measures model for analysis of continuous outcomes in sequential parallel comparison design studies.
-
A systematic overview of measurement-based care in the treatment of childhood and adolescent depression.
-
A systematic review of relations between resting-state functional-MRI and treatment response in major depressive disorder.
-
A systematic review of treatments for refractory depression in older people.
-
AGTR1 gene variation: association with depression and frontotemporal morphology.
-
APOE genotype and hippocampal volume change in geriatric depression.
-
Acetyl-l-carnitine deficiency in patients with major depressive disorder.
-
Achievement and maintenance of sustained response during the Treatment for Adolescents With Depression Study continuation and maintenance therapy.
-
Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
-
Acute time to response in the Treatment for Adolescents with Depression Study (TADS).
-
Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypes.
-
Adequacy of antidepressant treatment by psychiatric residents: the antidepressant treatment history form as a possible assessment tool.
-
Adjunctive brexpiprazole for the treatment of major depressive disorder.
-
Adjunctive use of olanzapine in mood disorders: five case reports.
-
Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults.
-
Affective context interferes with cognitive control in unipolar depression: an fMRI investigation.
-
Age differences in symptom expression in patients with major depression.
-
Age-related characteristics of depression: a preliminary STAR*D report.
-
Allelic differences in the brain-derived neurotrophic factor Val66Met polymorphism in late-life depression.
-
Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder.
-
Amygdala volume in late-life depression: relationship with age of onset.
-
Amyloid-associated depression: a prodromal depression of Alzheimer disease?
-
An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression.
-
An Electrophysiological Biomarker That May Predict Treatment Response to ECT.
-
An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials.
-
An ecological-transactional model of significant risk factors for child psychopathology in outer mongolia.
-
An exploration of comorbid depression among female victims of intimate partner violence with posttraumatic stress disorder.
-
An exploratory analysis of the impact of family functioning on treatment for depression in adolescents.
-
An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial.
-
Anger, social support, and suicide risk in U.S. military veterans.
-
Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders.
-
Antidepressant response to electroconvulsive therapy is sustained after catecholamine depletion.
-
Anxiety and depressive disorders and the five-factor model of personality: a higher- and lower-order personality trait investigation in a community sample.
-
Anxiety reduces baroreflex cardiac control in older adults with major depression.
-
Appetite and Weight Loss Symptoms in Late-Life Depression Predict Dementia Outcomes.
-
Appetite loss and neurocognitive deficits in late-life depression.
-
Applications of TMS to therapy in psychiatry.
-
Are Patients with Childhood Onset of Insomnia and Depression More Difficult to Treat Than Are Those with Adult Onsets of These Disorders? A Report from the TRIAD Study.
-
Ascending digits task as a measure of executive function in geriatric depression.
-
Assessing patient beliefs in a clinical trial of Hypericum perforatum in major depression.
-
Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute working group report.
-
Assessment of safety and long-term outcomes of initial treatment with placebo in TADS.
-
Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis.
-
Association of AGTR1 with 18-month treatment outcome in late-life depression.
-
Association of DHEA, DHEAS, and cortisol with childhood trauma exposure and post-traumatic stress disorder.
-
Association of attentional shift and reversal learning to functional deficits in geriatric depression.
-
Association of five-factor model personality domains and facets with presence, onset, and treatment outcomes of major depression in older adults.
-
Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive L-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs.
-
Association of somatic symptoms with depression and anxiety in clinical patients of general hospitals in Guangzhou, China.
-
Associations between sleep difficulties and risk factors for cardiovascular disease in veterans and active duty military personnel of the Iraq and Afghanistan conflicts.
-
Attenuation of Frontostriatal Connectivity During Reward Processing Predicts Response to Psychotherapy in Major Depressive Disorder.
-
Atypical depression: a comprehensive review.
-
BDNF Val66Met genotype and 6-month remission rates in late-life depression.
-
Baroreceptor sensitivity at rest and during stress in women with posttraumatic stress disorder or major depressive disorder.
-
Basolateral amygdala volume and cell numbers in major depressive disorder: a postmortem stereological study.
-
Behavioral and emotional disturbances in the offspring of depressed parents with anger attacks.
-
Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics.
-
Better, Faster, Safer: Exploring Biomarkers of Response to Transform Electroconvulsive Therapy.
-
Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial.
-
Biochemical abnormalities of the medial temporal lobe and medial prefrontal cortex in late-life depression.
-
Bioequivalence and Therapeutic Equivalence of Generic and Brand Bupropion in Adults With Major Depression: A Randomized Clinical Trial.
-
Biological and social predictors of long-term geriatric depression outcome.
-
Bipolar disorder is associated with HIV transmission risk behavior among patients in treatment for HIV.
-
Brain network functional connectivity and cognitive performance in major depressive disorder.
-
Brexpiprazole as an adjunctive treatment in young adults with major depressive disorder who are in a school or work environment.
-
Brief pulse and ultrabrief pulse right unilateral electroconvulsive therapy (ECT) for major depression: efficacy, effectiveness, and cognitive effects.
-
Cardiovascular disease risk, vascular health and erectile dysfunction among middle-aged, clinically depressed men.
-
Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile.
-
Cerebrovascular risk factors and cerebral hyperintensities among middle-aged and older adults with major depression.
-
Cerebrovascular risk factors, vascular disease, and neuropsychological outcomes in adults with major depression.
-
Challenging assumptions from emotion dysregulation psychological treatments.
-
Childhood traumatic stress and obesity in women: the intervening effects of PTSD and MDD.
-
Chronic SSRI treatment exacerbates serotonin deficiency in humanized Tph2 mutant mice.
-
Church attendance and new episodes of major depression in a community study of older adults: the Cache County Study.
-
Cingulum bundle white matter lesions influence antidepressant response in late-life depression: a pilot study.
-
Coexistence of urinary incontinence and major depressive disorder with health-related quality of life in older Americans with and without cancer.
-
Cognitive Behavioral Insomnia Therapy for Those With Insomnia and Depression: A Randomized Controlled Clinical Trial.
-
Cognitive aspects of chronic depression.
-
Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial.
-
Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review.
-
Cognitive effects of transcranial direct current stimulation treatment in patients with major depressive disorder: An individual patient data meta-analysis of randomised, sham-controlled trials.
-
Cognitive enhancing effects of rTMS administered to the prefrontal cortex in patients with depression: A systematic review and meta-analysis of individual task effects.
-
Cognitive functioning throughout the treatment history of clinical late-life depression.
-
Cognitive measures of adolescent depression: unique or unitary constructs?
-
Cognitive performance in antidepressant-free recurrent major depressive disorder.
-
Cognitive-behavioral therapy for suicide prevention (CBT-SP): treatment model, feasibility, and acceptability.
-
Combined Treatment for Obesity and Depression: A Pilot Study.
-
Combined catecholamine and indoleamine depletion following response to ECT.
-
Comment on Nasrallah et al: lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol.
-
Comorbid substance and mental disorders among rural Americans: results from the National Comorbidity Survey.
-
Comorbidity and depression treatment.
-
Comparative efficacy of cognitive behavioral therapy, fluoxetine, and their combination in depressed adolescents: initial lessons from the treatment for adolescents with depression study.
-
Comparison of academic and nonacademic sites in multi-center clinical trials.
-
Comparison of brain structural variables, neuropsychological factors, and treatment outcome in early-onset versus late-onset late-life depression.
-
Comparison of major and minor depression in older medical inpatients with chronic heart and pulmonary disease.
-
Comparison of older depressed hospitalized patients with and without heart failure/pulmonary disease.
-
Comparison of post-disaster psychiatric disorders after terrorist bombings in Nairobi and Oklahoma City.
-
Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT.
-
Computerized cognitive training and functional recovery in major depressive disorder: A meta-analysis.
-
Concerns about data reporting and interpretation in "Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial".
-
Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression.
-
Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).
-
Cost-effectiveness of improving primary care treatment of late-life depression.
-
Cost-effectiveness of treatments for adolescent depression: results from TADS.
-
Cross-cultural considerations in administering the center for epidemiologic studies depression scale.
-
DHEA metabolism to the neurosteroid androsterone: a possible mechanism of DHEA's antidepressant action.
-
Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial.
-
Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.
-
Decreased Resting-State Activity in the Precuneus Is Associated With Depressive Episodes in Recurrent Depression.
-
Default mode network connectivity in children with a history of preschool onset depression.
-
Defining treatment-resistant depression: a comprehensive review of the literature.
-
Depressed adolescents and comorbid psychiatric disorders: are there differences in the presentation of depression?
-
Depressed older patients with the atypical features of interpersonal rejection sensitivity and reversed-vegetative symptoms are similar to younger atypical patients.
-
Depression Among Older Adults: A 20-Year Update on Five Common Myths and Misconceptions.
-
Depression after successful treatment for nonsmall cell lung carcinoma.
-
Depression among military spouses: Demographic, military, and service member psychological health risk factors.
-
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life.
-
Depression and five year survival following acute myocardial infarction: a prospective study.
-
Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years.
-
Depression in Taiwanese patients with Alzheimer's disease determined by the National Institutes of Mental Health Provisional Criteria.
-
Depression in chronic illness: does religion help?
-
Depression in patients with colorectal cancer in Saudi Arabia.
-
Depression outcome in inpatients with congestive heart failure.
-
Depression, suicidality, and alcohol use disorder among people living with HIV/AIDS in Nigeria.
-
Depressive morbidity and gender in community-dwelling Brazilian elderly: systematic review and meta-analysis.
-
Depressive state- and disease-related alterations in neural responses to affective and executive challenges in geriatric depression.
-
Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters (TASA) Study.
-
Desvenlafaxine, a serotonin-norepinephrine uptake inhibitor for major depressive disorder, neuropathic pain and the vasomotor symptoms associated with menopause.
-
Detection of depression in low resource settings: validation of the Patient Health Questionnaire (PHQ-9) and cultural concepts of distress in Nepal.
-
Development of a semi-automated method for quantification of MRI gray and white matter lesions in geriatric subjects.
-
Diagnostic specificity and nonspecificity in the dimensions of preschool psychopathology.
-
Diagnostic utility of the Quick Inventory of Depressive Symptomatology (QIDS-C16 and QIDS-SR16) in the elderly.
-
Differences between depressed patients with heart failure and those with pulmonary disease.
-
Differences between suicide attempters and nonattempters in depressed older patients: depression severity, white-matter lesions, and cognitive functioning.
-
Differences in behavioral health disorders and unmet treatment needs between medical marijuana users and recreational marijuana users: Results from a national adult sample.
-
Differences in early childhood risk factors for juvenile-onset and adult-onset depression.
-
Dimensions of social support and depression in patients at increased psychosocial risk recovering from myocardial infarction.
-
Direct Participation in and Indirect Exposure to the Occupy Central Movement and Depressive Symptoms: A Longitudinal Study of Hong Kong Adults.
-
Disability but not social support predicts cognitive deterioration in late-life depression.
-
Discussing Out-of-Pocket Expenses During Clinical Appointments: An Observational Study of Patient-Psychiatrist Interactions.
-
Disrupted amygdala reactivity in depressed 4- to 6-year-old children.
-
Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women.
-
Does Childhood Trauma Moderate Polygenic Risk for Depression? A Meta-analysis of 5765 Subjects From the Psychiatric Genomics Consortium.
-
Does a coexisting anxiety disorder predict persistence of depressive illness in primary care patients with major depression?
-
Does change in ECT electrode placement help temporomandibular joint pain?
-
Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study.
-
Dynamic Resting-State Functional Connectivity in Major Depression.
-
Dynamically Timed Stimulation of Corticolimbic Circuitry Activates a Stress-Compensatory Pathway.
-
Dysfunctional attitudes scale perfectionism: a predictor and partial mediator of acute treatment outcome among clinically depressed adolescents.
-
Dysregulation of Prefrontal Cortex-Mediated Slow-Evolving Limbic Dynamics Drives Stress-Induced Emotional Pathology.
-
ECT and TMS: past, present, and future.
-
ECT use in unipolar and bipolar depression.
-
EEG effects of ECT: implications for rTMS.
-
EFFECTS OF RELIGIOUS VERSUS STANDARD COGNITIVE-BEHAVIORAL THERAPY ON OPTIMISM IN PERSONS WITH MAJOR DEPRESSION AND CHRONIC MEDICAL ILLNESS.
-
Easing the burden of social anxiety disorder.
-
Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.
-
Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression.
-
Effect of bupropion extended release on negative emotion processing in major depressive disorder: a pilot functional magnetic resonance imaging study.
-
Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study.
-
Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects.
-
Effects of Adjunctive Brexpiprazole on Sleep Disturbances in Patients With Major Depressive Disorder: An Open-Label, Flexible-Dose, Exploratory Study.
-
Effects of Exercise and Sertraline on Measures of Coronary Heart Disease Risk in Patients With Major Depression: Results From the SMILE-II Randomized Clinical Trial.
-
Effects of a Course of Right Unilateral Ultrabrief Pulse Electroconvulsive Therapy Combined With Venlafaxine on Insomnia Symptoms in Elderly Depressed Patients.
-
Effects of continuation electroconvulsive therapy on quality of life in elderly depressed patients: A randomized clinical trial.
-
Effects of early life stress on depression, cognitive performance and brain morphology.
-
Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy.
-
Effects of religious vs. standard cognitive behavioral therapy on therapeutic alliance: A randomized clinical trial.
-
Effects on Daily Spiritual Experiences of Religious Versus Conventional Cognitive Behavioral Therapy for Depression.
-
Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression.
-
Efficacy and acceptability of transcranial direct current stimulation (tDCS) for major depressive disorder: An individual patient data meta-analysis.
-
Efficacy and safety of St. John's wort for the treatment of major depression.
-
Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysis.
-
Efficacy of Cognitive-Behavioral Therapy for Insomnia Combined With Antidepressant Pharmacotherapy in Patients With Comorbid Depression and Insomnia: A Randomized Controlled Trial.
-
Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial.
-
Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies.
-
Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials.
-
Electric field characteristics of low-field synchronized transcranial magnetic stimulation (sTMS).
-
ElectroConvulsive therapy Cognitive Assessment (ECCA) tool: A new instrument to monitor cognitive function in patients undergoing ECT.
-
Electroconvulsive Therapy and All-Cause Mortality in Texas, 1998-2013.
-
Electroconvulsive therapy (ECT) for moderate-severity major depression among the elderly: Data from the pride study.
-
Electroconvulsive therapy device classification: response to FDA advisory panel hearing and recommendations.
-
Electroconvulsive therapy for depression.
-
Electroconvulsive therapy for severe major depressive disorder after orthotopic liver transplantation.
-
Electroconvulsive therapy in the United States: how often is it used?
-
Electroconvulsive therapy is equally effective in unipolar and bipolar depression.
-
Electroconvulsive therapy: how effective is it?
-
Elevated brain lesion volumes in older adults who use calcium supplements: a cross-sectional clinical observational study.
-
Elevated inflammation levels in depressed adults with a history of childhood maltreatment.
-
Elevation in plasma Abeta42 in geriatric depression: a pilot study.
-
Emotion Regulation in Borderline Personality Disorder: An Experimental Investigation of the Effects of Instructed Acceptance and Suppression.
-
Empirically derived subtypes of adolescent depression: latent profile analysis of co-occurring symptoms in the Treatment for Adolescents with Depression Study (TADS).
-
Epigenetic upregulation of FKBP5 by aging and stress contributes to NF-κB-driven inflammation and cardiovascular risk.
-
Ethnic differences among adolescents beginning treatment for depression.
-
Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression.
-
Evaluation of lifetime trauma exposure and physical health in women with posttraumatic stress disorder or major depressive disorder.
-
Evidence for impaired cortical inhibition in patients with unipolar major depression.
-
Evidence of early retinal microvascular changes in patients with type 2 diabetes and depression.
-
Examining the factor structure of the Connor-Davidson Resilience Scale (CD-RISC) in a post-9/11 U.S. military veteran sample.
-
Exercise and pharmacotherapy in patients with major depression: one-year follow-up of the SMILE study.
-
Exercise and pharmacotherapy in the treatment of major depressive disorder.
-
Exercise fails to improve neurocognition in depressed middle-aged and older adults.
-
Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months.
-
Factor structure and psychometric properties of the Children's Negative Cognitive Error Questionnaire with a clinically depressed adolescent sample.
-
Family history of depression and therapeutic outcome: findings from STAR*D.
-
Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion.
-
Fiber tract-specific white matter lesion severity Findings in late-life depression and by AGTR1 A1166C genotype.
-
Financial well-being and postdeployment adjustment among Iraq and Afghanistan war veterans.
-
Five-year trajectories of social networks and social support in older adults with major depression.
-
Flexible dosing schedules for continuation electroconvulsive therapy.
-
Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
-
Focal and lateralized subcortical abnormalities in unipolar major depressive disorder: an automated multivoxel proton magnetic resonance spectroscopy study.
-
Focal brain stimulation with repetitive transcranial magnetic stimulation (rTMS): implications for the neural circuitry of depression.
-
Follow-up visits by provider specialty for patients with major depressive disorder initiating antidepressant treatment.
-
Food group intake and brain lesions in late-life vascular depression.
-
Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies.
-
Functional brain activation to emotionally valenced faces in school-aged children with a history of preschool-onset major depression.
-
Functional connectivity of the amygdala in early-childhood-onset depression.
-
Functional connectivity predictors of acute depression treatment outcome.
-
Functional connectivity: a source of variance in the association between cardiorespiratory fitness and cognition?
-
Functioning and interpersonal relationships as predictors of response in treatment-resistant depression.
-
Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS).
-
Gender differences in the association between religious involvement and depression: the Cache County (Utah) study.
-
General medical and specialty mental health service use for major depression.
-
Generalized anxiety disorder and depression: childhood risk factors in a birth cohort followed to age 32.
-
Genetic Association of Major Depression With Atypical Features and Obesity-Related Immunometabolic Dysregulations.
-
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs.
-
Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.
-
Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression.
-
Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients.
-
Genome-wide interaction study of a proxy for stress-sensitivity and its prediction of major depressive disorder.
-
Geriatric depression and cognitive impairment.
-
Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics.
-
Greater MRI lesion volumes in elderly depressed subjects than in control subjects.
-
Grey-matter lesions and dementia.
-
Guideline-concordant antidepressant use among patients with major depressive disorder.
-
Hazardous drinking and clinical correlates among suicidal patients receiving psychiatric inpatient care at military medical settings.
-
Head injury in early adulthood and the lifetime risk of depression.
-
Heterogeneity in symptom profiles among older adults diagnosed with major depression.
-
Heterogeneity in the three-year course of major depression among older adults.
-
Hippocampal structural and functional changes associated with electroconvulsive therapy response.
-
Hippocampal volume as a predictor of short-term ECT outcomes in older patients with depression.
-
Hippocampal volume in geriatric depression.
-
Hippocampal volume is associated with physician-reported acute cognitive deficits after electroconvulsive therapy.
-
Hippocampus atrophy and the longitudinal course of late-life depression.
-
History of depression and survival after acute myocardial infarction.
-
Hormone therapy does not affect depression severity in older women.
-
Hyperforin plasma level as a marker of treatment adherence in the National Institutes of Health Hypericum Depression Trial.
-
Identifying depression in primary care: a literature synthesis of case-finding instruments.
-
Impact of childhood trauma on treatment outcome in the Treatment for Adolescents with Depression Study (TADS).
-
Impact of comorbid panic and posttraumatic stress disorder on outcomes of collaborative care for late-life depression in primary care.
-
Impact of depression and anxiety on the quality of life of constipated patients.
-
Impact of diagnosis and treatment of clinically localized prostate cancer on health-related quality of life for older Americans: a population-based study.
-
Impact of second-generation antipsychotics and perphenazine on depressive symptoms in a randomized trial of treatment for chronic schizophrenia.
-
Impact of sleep complaints and depression outcomes among participants in the standard medical intervention and long-term exercise study of exercise and pharmacotherapy for depression.
-
Impact of symptoms of generalized anxiety disorder on the course of late-life depression.
-
Improvement in quality of life with left prefrontal transcranial magnetic stimulation in patients with pharmacoresistant major depression: acute and six month outcomes.
-
Improvements in Depression and Changes in Fatigue: Results from the SLAM DUNC Depression Treatment Trial.
-
Improving depression outcomes in older adults with comorbid medical illness.
-
Increased plasma complement factor H is associated with geriatric depression.
-
Increased prevalence of falls among elderly individuals with mental health and substance abuse conditions.
-
Increased ventromedial prefrontal cortex activity and connectivity predict poor sertraline treatment outcome in late-life depression.
-
Increasing the validity of experimental models for depression.
-
Inflammation Markers and Major Depressive Disorder in Patients With Chronic Heart Failure: Results From the Sertraline Against Depression and Heart Disease in Chronic Heart Failure Study.
-
Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression.
-
Insight in first-episode psychosis.
-
Instrumental variable estimation of causal odds ratios using structural nested mean models.
-
Interaction of oxytocin level and past depression may predict postpartum depressive symptom severity.
-
Interactive effect of substance abuse and depression on adolescent social competence.
-
International consensus statement on major depressive disorder.
-
International randomized-controlled trial of transcranial Direct Current Stimulation in depression.
-
Intima-media thickness and age of first depressive episode.
-
Intravenous Ketamine Relieves Pain and Depression After Traumatic Suicide Attempts: A Case Series.
-
Is Major Depression Linked to Alcohol-Impaired Driving?
-
Is depression associated with immune activation?
-
Is depression associated with microvascular disease in patients with type 2 diabetes?
-
Is there protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder.
-
Joint analysis of psychiatric disorders increases accuracy of risk prediction for schizophrenia, bipolar disorder, and major depressive disorder.
-
Key updates in the clinical application of electroconvulsive therapy.
-
Largest GWAS of PTSD (N=20 070) yields genetic overlap with schizophrenia and sex differences in heritability.
-
Late-life Depression Modifies the Association Between Cerebral White Matter Hyperintensities and Functional Decline Among Older Adults.
-
Late-life depression and microstructural abnormalities in dorsolateral prefrontal cortex white matter.
-
Left dorsolateral prefrontal transcranial magnetic stimulation (TMS): sleep factor changes during treatment in patients with pharmacoresistant major depressive disorder.
-
Length of axons expressing the serotonin transporter in orbitofrontal cortex is lower with age in depression.
-
Lessons from SADHART, ENRICHD, and other trials.
-
Life Span Studies of ADHD-Conceptual Challenges and Predictors of Persistence and Outcome.
-
Lifetime major depression and comorbid disorders among current-era women veterans.
-
Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder.
-
Localization of age-associated white matter hyperintensities in late-life depression.
-
Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial.
-
Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study.
-
Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression.
-
Low yield of thyroid-stimulating hormone testing in elderly patients with depression.
-
Low-dose augmentation with buprenorphine increases emotional reactivity but not reward activity in treatment resistant mid- and late-life depression.
-
Magnetic seizure therapy (MST) for major depressive disorder.
-
Magnetic seizure therapy improves mood in refractory major depression.
-
Major depression and physical illness trajectories in heart failure and pulmonary disease.
-
Major depression, antidepressant use, and male and female fertility.
-
Major depression, generalized anxiety disorder, and panic disorder in patients scheduled for knee arthroplasty.
-
Major depressive disorder is characterized by greater reward network activation to monetary than pleasant image rewards.
-
Major depressive disorder treatment guidelines in America and Europe.
-
Major depressive disorder with psychotic features may lead to misdiagnosis of dementia: a case report and review of the literature.
-
Managing depression in countries with low and middle incomes: an imperative for human immunodeficiency virus/acquired immune deficiency syndrome care and treatment and general public health.
-
Managing depression in geriatric populations.
-
Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders.
-
Medial orbital frontal lesions in late-onset depression.
-
Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives.
-
Medication-Assisted Treatment for Alcohol-Dependent Adults With Serious Mental Illness and Criminal Justice Involvement: Effects on Treatment Utilization and Outcomes.
-
Mental health service use among adolescents following participation in a randomized clinical trial for depression.
-
Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder.
-
Metabolomic differences in heart failure patients with and without major depression.
-
Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients.
-
Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants.
-
Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
-
Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders.
-
Methodology and preliminary results from the neurocognitive outcomes of depression in the elderly study.
-
Microvascular Endothelial Function and Neurocognition Among Adults With Major Depressive Disorder.
-
Milnacipran: beyond a role of antidepressant.
-
Minor depression in family practice: functional morbidity, co-morbidity, service utilization and outcomes.
-
Modification of depression by COMT val158met polymorphism in children exposed to early severe psychosocial deprivation.
-
More data on speed of remission with ECT in geriatric depression.
-
Morphometric analysis of vascular pathology in the orbitofrontal cortex of older subjects with major depression.
-
National dissemination of interpersonal psychotherapy for depression in veterans: therapist and patient-level outcomes.
-
Negative Affectivity, Aging, and Depression: Results From the Neurobiology of Late-Life Depression (NBOLD) Study.
-
Neighborhood structural characteristics and mental disorder: Faris and Dunham revisited.
-
Neural indicators of emotion regulation via acceptance vs reappraisal in remitted major depressive disorder.
-
Neural mechanisms of cognitive reappraisal in remitted major depressive disorder.
-
Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Venlafaxine in Geriatric Depression: Phase 1 of the PRIDE Study.
-
Neurocognitive correlates of response to treatment in late-life depression.
-
Neurocognitive effects of transcranial direct current stimulation (tDCS) in unipolar and bipolar depression: Findings from an international randomized controlled trial.
-
Neurocognitive subgroups in major depressive disorder.
-
Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis.
-
Neuropsychological predictors of dementia in late-life major depressive disorder.
-
Neurosteroid Levels in Patients With Bipolar Disorder and a History of Cannabis Use Disorders.
-
Neuroticism Traits Selectively Impact Long Term Illness Course and Cognitive Decline in Late-Life Depression.
-
New developments in electroconvulsive therapy and magnetic seizure therapy.
-
Normal personality traits and comorbidity among phobic, panic and major depressive disorders.
-
On the Concurrent Use of Self-System Therapy and Functional Magnetic Resonance Imaging-Guided Transcranial Magnetic Stimulation as Treatment for Depression.
-
Onset of alcohol or substance use disorders following treatment for adolescent depression.
-
Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms.
-
Partial remission. A common outcome in older adults treated for major depression.
-
Partial response as a predictor of outcome in geriatric depression.
-
Pastoral care use among post-9/11 veterans who screen positive for mental health problems.
-
Pathophysiology of hypercortisolism in depression.
-
Pathophysiology of hypercortisolism in depression: pituitary and adrenal responses to low glucocorticoid feedback.
-
Patterns and correlates of major depression in Chinese adults: a cross-sectional study of 0.5 million men and women.
-
Performance feedback deficit in geriatric depression.
-
Persistent mild cognitive impairment in geriatric depression.
-
Personality and differential treatment response in major depression: a randomized controlled trial comparing cognitive-behavioural therapy and pharmacotherapy.
-
Personality--life event congruence effects in late-life depression.
-
Perspectives on depression, mild cognitive impairment, and cognitive decline.
-
Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo.
-
Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder - possible role for methoxyindole pathway.
-
Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology.
-
Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive Disorder.
-
Physical and sexual abuse, depression and alcohol use disorders in adolescents: onsets and outcomes.
-
Physical frailty in late-life depression is associated with deficits in speed-dependent executive functions.
-
Physician attitudes toward treatment of depression in older medical inpatients.
-
Plasma omega-3 polyunsaturated fatty acids and survival in patients with chronic heart failure and major depressive disorder.
-
Posttraumatic stress disorder and traumatic brain Injury: Sex differences in veterans.
-
Practitioner review: the assessment of bipolar disorder in children and adolescents.
-
Pre-treatment attentional processing speed and antidepressant response to transcranial direct current stimulation: Results from an international randomized controlled trial.
-
Precision non-implantable neuromodulation therapies: a perspective for the depressed brain.
-
Predictive value of family history on severity of illness: the case for depression, anxiety, alcohol dependence, and drug dependence.
-
Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).
-
Predictors of depression outcomes in medical inpatients with chronic pulmonary disease.
-
Predictors of depression recovery in HIV-infected individuals managed through measurement-based care in infectious disease clinics.
-
Predictors of hopelessness among clinically depressed youth.
-
Predictors of partial remission in older patients treated for major depression: the role of comorbid dysthymia.
-
Predictors of recurrence in remitted late-life depression.
-
Prefrontal cortex, thalamus, and cerebellar volumes in adolescents and young adults with adolescent-onset alcohol use disorders and comorbid mental disorders.
-
Prefrontal mechanisms for executive control over emotional distraction are altered in major depression.
-
Prenatal dysthymia versus major depression effects on maternal cortisol and fetal growth.
-
Prescription pain reliever abuse and dependence among adolescents: a nationally representative study.
-
Pretreatment brain connectivity during positive emotion upregulation predicts decreased anhedonia following behavioral activation therapy for depression.
-
Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept.
-
Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept.
-
Prevalence and costs of major depression among elderly claimants with diabetes.
-
Prevalence and factors associated with diagnosed depression among hospitalized cancer patients with metastatic disease.
-
Prevalence and incidence of probable perinatal depression among women enrolled in Option B+ antenatal HIV care in Malawi.
-
Prevalence and sociodemographic factors associated with depression among hospitalized patients with head and neck cancer-Results from a national study.
-
Prevalence of obstructive sleep apnea in suicidal patients with major depressive disorder.
-
Prevalence, course, and predictors of emotional distress in pregnant and parenting adolescents.
-
Probability of major depression diagnostic classification using semi-structured versus fully structured diagnostic interviews.
-
Problem alcohol use and healthcare utilization among persons with cannabis use disorder in the United States.
-
Profiles of depressive symptoms in older adults diagnosed with major depression: latent cluster analysis.
-
Psychiatric Care of the Post-September 11 Combat Veteran: A Review.
-
Psychiatric Comorbidity of Unipolar Mood, Anxiety, and Trauma Disorders Prior to HIV Testing and the Effect on Linkage to Care Among HIV-Infected Adults in South Africa.
-
Psychiatric comorbidity in depressed HIV-infected individuals: common and clinically consequential.
-
Psychomotor retardation in depression: biological underpinnings, measurement, and treatment.
-
Psychosocial Predictors of Mortality Following Lung Transplantation.
-
Psychosocial and clinical predictors of unipolar depression outcome in older adults.
-
Psychosocial and physical correlates of chronic depression.
-
Puberty and depression.
-
Putamen Volume Differences Among Older Adults: Depression Status, Melancholia, and Age.
-
Quality of life and physical activity associated to lower prevalence of depression in community-dwelling elderly subjects from Sao Paulo.
-
Quality of life in geriatric depression: a comparison of remitters, partial responders, and nonresponders.
-
Quantifying heterogeneity attributable to polythetic diagnostic criteria: theoretical framework and empirical application.
-
Quetiapine XR: current status for the treatment of major depressive disorder.
-
Quick recovery of orientation after magnetic seizure therapy for major depressive disorder.
-
RCT of a psychological intervention for patients with cancer: I. mechanisms of change.
-
Race/ethnicity differences between alcohol, marijuana, and co-occurring alcohol and marijuana use disorders and their association with public health and social problems using a national sample.
-
Randomized sham controlled trial of repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex for the treatment of panic disorder with comorbid major depression.
-
Randomized trial of pallidotomy versus medical therapy for Parkinson's disease.
-
Rapid increase in the prevalence of cannabis use among people with depression in the United States, 2005-17: the role of differentially changing risk perceptions.
-
Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy.
-
Recognition of depression in medical patients with heart failure.
-
Recovery and recurrence following treatment for adolescent major depression.
-
Reducing barriers to completing psychiatric advance directives.
-
Reductions in neuronal density in elderly depressed are region specific.
-
Relapse of depression after electroconvulsive therapy.
-
Relationship Between Chronic Conditions and Disability in African American Men and Women.
-
Relationship between traumatic brain injury history and recent suicidal ideation in Iraq/Afghanistan-era veterans.
-
Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure.
-
Relative cost-effectiveness of treatments for adolescent depression: 36-week results from the TADS randomized trial.
-
Relative effectiveness of reappraisal and distraction in regulating emotion in late-life depression.
-
Reliability and Validity of the Vietnamese Depression Interview (VDI).
-
Religion and depression in older medical inpatients.
-
Religion and remission of depression in medical inpatients with heart failure/pulmonary disease.
-
Religion and the presence and severity of depression in older adults.
-
Religion, spirituality, and depression in adolescent psychiatric outpatients.
-
Religion, spirituality, and mental health of U.S. military veterans: Results from the National Health and Resilience in Veterans Study.
-
Religion/spirituality and depression: what can we learn from empirical studies?
-
Religious service attendance and major depression: a case of reverse causality?
-
Religious vs. conventional cognitive behavioral therapy for major depression in persons with chronic medical illness: a pilot randomized trial.
-
Religiously integrated cognitive behavioral therapy: a new method of treatment for major depression in patients with chronic medical illness.
-
Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes.
-
Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS).
-
Remitted major depression is characterized by reduced prefrontal cortex reactivity to reward loss.
-
Remitted major depression is characterized by reward network hyperactivation during reward anticipation and hypoactivation during reward outcomes.
-
Repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of panic disorder (PD) with comorbid major depression.
-
Repetitive Transcranial Magnetic Stimulation of the Supplementary Motor Area in the treatment of Tourette Syndrome: report of two cases.
-
Reply to: Declining use of electroconvulsive therapy in U.S. general hospitals is not restricted to unipolar depression.
-
Research knowledge among the participants in the Treatment for Adolescents With Depression Study (TADS).
-
Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication.
-
Residual symptoms in older patients treated for major depression.
-
Resolution of trauma-related guilt following treatment of PTSD in female rape victims: a result of cognitive processing therapy targeting comorbid depression?
-
Resolved: psychosocial interventions can improve clinical outcomes in organic disease (pro).
-
Response inhibition predicts poor antidepressant treatment response in very old depressed patients.
-
Response to Zhang et al. (2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45, 11-16.
-
Resting-state connectivity predictors of response to psychotherapy in major depressive disorder.
-
Resting-state mapping of neural signatures of vulnerability to depression relapse.
-
Results from 2 randomized, double-blind, placebo-controlled studies of the novel NK1 receptor antagonist casopitant in patients with major depressive disorder.
-
Role of inflammation in depression relapse.
-
Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy.
-
Screening for Major Depressive Disorder in Children and Adolescents: A Systematic Review for the U.S. Preventive Services Task Force.
-
Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools in the NRG Oncology RTOG 0841 trial.
-
Seize the Day to Implement Depression Guidelines.
-
Seizure induction with low-amplitude-current (0.5 A) electroconvulsive therapy.
-
Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial.
-
Self-punishment as a regulation strategy in borderline personality disorder.
-
Self-regulation, rumination, and vulnerability to depression in adolescent girls.
-
Self-reported health and physician diagnosed illnesses in women with posttraumatic stress disorder and major depressive disorder.
-
Self-reported pain complaints among Afghanistan/Iraq era men and women veterans with comorbid posttraumatic stress disorder and major depressive disorder.
-
Sensitivity of cognitive tests in four cognitive domains in discriminating MDD patients from healthy controls: a meta-analysis.
-
Serotonin syndrome in a chronic-pain patient receiving concurrent methadone, ciprofloxacin, and venlafaxine.
-
Serotonin transporter gene moderates childhood maltreatment's effects on persistent but not single-episode depression: replications and implications for resolving inconsistent results.
-
Sertraline and the Cheshire cat in geriatric depression.
-
Sertraline treatment of major depression in patients with acute MI or unstable angina.
-
Service use and costs of care for depressed adolescents: who uses and who pays?
-
Shifting priorities: highly conserved behavioral and brain network adaptations to chronic stress across species.
-
Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.
-
Short/long heterozygotes at 5HTTLPR and white matter lesions in geriatric depression.
-
Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia.
-
Smoking-induced affect modulation in nonwithdrawn smokers with posttraumatic stress disorder, depression, and in those with no psychiatric disorder.
-
Social support and locus of control as predictors of adherence to antidepressant medication in an elderly population.
-
Social support modifies the relationship between personality and depressive symptoms in older adults.
-
Somatic, positive and negative domains of the Center for Epidemiological Studies Depression (CES-D) scale: a meta-analysis of genome-wide association studies.
-
Specific psychotherapies for childhood and adolescent depression.
-
Speed of response to electroconvulsive therapy compared with ketamine.
-
Spirituality and distress in sheltered battered women.
-
St John's wort and depression.
-
State of the Science of Neural Systems in Late-Life Depression: Impact on Clinical Presentation and Treatment Outcome.
-
State-dependent responses to intracranial brain stimulation in a patient with depression.
-
Stressful life events, perceived stress, and 12-month course of geriatric depression: direct effects and moderation by the 5-HTTLPR and COMT Val158Met polymorphisms.
-
Structural brain changes as biomarkers and outcome predictors in patients with late-life depression: a cross-sectional and prospective study.
-
Structural-functional correlations between hippocampal volume and cortico-limbic emotional responses in depressed children.
-
Study design and methodology for a multicentre, randomised controlled trial of transcranial direct current stimulation as a treatment for unipolar and bipolar depression.
-
Subcortical lesion severity and orbitofrontal cortex volume in geriatric depression.
-
Subcortical white matter lesions and functional impairment in geriatric depression.
-
Suicidal events in the Treatment for Adolescents With Depression Study (TADS).
-
Suicide Behaviors in Bipolar Disorder: A Review and Update for the Clinician.
-
Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial.
-
Sustained anterior cingulate cortex activation during reward processing predicts response to psychotherapy in major depressive disorder.
-
Systematic review of multifaceted interventions to improve depression care.
-
TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics.
-
Test of mindfulness and hope components in a psychological intervention for women with cancer recurrence.
-
Testing a social-cognitive model of HIV transmission risk behaviors in HIV-infected MSM with and without depression.
-
Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs).
-
Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder.
-
The 2-week duration criterion and severity and course of early childhood depression: implications for nosology.
-
The Accuracy of the Patient Health Questionnaire-9 Algorithm for Screening to Detect Major Depression: An Individual Participant Data Meta-Analysis.
-
The Genomics of Electroconvulsive Therapy International Consortium (GenECT-ic).
-
The National Lesbian Family Study: 3. Interviews with mothers of five-year-olds.
-
The Treatment for Adolescents With Depression Study (TADS): demographic and clinical characteristics.
-
The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.
-
The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up.
-
The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks.
-
The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in an open treatment trial.
-
The Use of Antidepressants in Bipolar Depression.
-
The association between cognitive function and subsequent depression: a systematic review and meta-analysis.
-
The bidirectional relationships between alcohol, cannabis, co-occurring alcohol and cannabis use disorders with major depressive disorder: results from a national sample.
-
The caregiving environments provided to children by depressed mothers with or without an antisocial history.
-
The critical warzone experiences (CWE) scale: initial psychometric properties and association with PTSD, anxiety, and depression.
-
The depression treatment cascade in primary care: a public health perspective.
-
The dysfunctional attitudes scale: psychometric properties in depressed adolescents.
-
The effects of Brief Behavioral Activation Therapy for Depression on cognitive control in affective contexts: An fMRI investigation.
-
The effects of aripiprazole on the subscales of the Kellner Symptom Questionnaire in treatment resistant depression.
-
The effects of psychotherapy on neural responses to rewards in major depression.
-
The efficacy of acute electroconvulsive therapy in atypical depression.
-
The emerging role for repetitive transcranial magnetic stimulation in optimizing the treatment of adolescent depression.
-
The epidemiology of trauma and post-traumatic stress disorder in a representative cohort of young people in England and Wales.
-
The impact of race on metabolic disease risk factors in women with and without posttraumatic stress disorder.
-
The impairment of Presidents Pierce and Coolidge after traumatic bereavement.
-
The influence of depressive symptoms on suicidal ideation among U.S. Vietnam-era and Afghanistan/Iraq-era veterans with posttraumatic stress disorder.
-
The influence of lifetime depression on self-reported memory and cognitive problems: results from the National Comorbidity Survey-Replication.
-
The influence of maternal stress and distress on disruptive behavior problems in boys.
-
The intricate link between violence and mental disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
-
The painfulness of active, but not sham, transcranial magnetic stimulation decreases rapidly over time: results from the double-blind phase of the OPT-TMS Trial.
-
The personality domains and styles of the five-factor model are related to incident depression in Medicare recipients aged 65 to 100.
-
The psychometric properties of the MASC in a pediatric psychiatric sample.
-
The relationship between fibromyalgia and major depressive disorder: a comprehensive review.
-
The relationship of MRI subcortical hyperintensities to treatment response in a trial of sertraline in geriatric depressed outpatients.
-
The relationship of person-specific eveningness chronotype, greater seasonality, and less rhythmicity to suicidal behavior: A literature review.
-
The role of readiness to change in response to treatment of adolescent depression.
-
The vascular depression subtype: evidence of internal validity.
-
Three- to four-year follow-up to an open trial of nefazodone for combat-related posttraumatic stress disorder.
-
Three-year incidence of first-onset depressive syndrome in a population sample of older adults: the Cache County study.
-
Thyroid hormones affect recovery from depression during antidepressant treatment.
-
Trait anger, anger expression, and suicide attempts among adolescents and young adults: a prospective study.
-
Trajectories of Functioning Into Emerging Adulthood Following Treatment for Adolescent Depression.
-
Trajectories of mobility and IADL function in older patients diagnosed with major depression.
-
Trajectories of preschool disorders to full DSM depression at school age and early adolescence: continuity of preschool depression.
-
Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial.
-
Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment.
-
Trauma-focused cognitive-behavioral therapy for posttraumatic stress disorder in three-through six year-old children: a randomized clinical trial.
-
Treating insomnia in depression: Insomnia related factors predict long-term depression trajectories.
-
Treatment course with antidepressant therapy in late-life depression.
-
Treatment for Adolescents With Depression Study (TADS): rationale, design, and methods.
-
Treatment for Adolescents with Depression Study (TADS): safety results.
-
Treatment of insomnia in depressed insomniacs: effects on health-related quality of life, objective and self-reported sleep, and depression.
-
Treatment of older adults with co-morbid personality disorder and depression: a dialectical behavior therapy approach.
-
Treatment of posttraumatic stress disorder reduces suicidal ideation.
-
Treatment of recurrent mental depression with imipramine.
-
Treatment response in depressed adolescents with and without co-morbid attention-deficit/hyperactivity disorder in the Treatment for Adolescents with Depression Study.
-
Trends and correlates of cocaine use and cocaine use disorder in the United States from 2011 to 2015.
-
Two Studies of Connectedness to Parents and Suicidal Thoughts and Behavior in Children and Adolescents.
-
Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes.
-
Unipolar depression does not moderate responses to the Sweet Taste Test.
-
Update on magnetic seizure therapy: a novel form of convulsive therapy.
-
Use of the SF-36v2 Health Survey as a Screen for Risk of Major Depressive Disorder in a US Population-based Sample and Subgroup With Chronic Pain.
-
VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms.
-
Vagus nerve stimulation. A potential therapy for resistant depression?
-
Vagus nerve stimulation: a new tool for brain research and therapy.
-
Validation of a treatment algorithm for major depression in an older Brazilian sample.
-
Validity of an interviewer-administered patient health questionnaire-9 to screen for depression in HIV-infected patients in Cameroon.
-
Vascular nutritional correlates of late-life depression.
-
Ventral striatum reactivity to reward and recent life stress interact to predict positive affect.
-
Vmat2 heterozygous mutant mice display a depressive-like phenotype.
-
What is the overlap between subjective and objective cognitive impairments in MDD?
-
White matter and subcortical gray matter lesion volume changes and late-life depression outcome: a 4-year magnetic resonance imaging study.
-
White matter hyperintensity progression and late-life depression outcomes.
-
White matter lesion volumes and caudate volumes in late-life depression.
-
Why do trauma survivors become depressed? Testing the behavioral model of depression in a nationally representative sample.
-
Work stress precipitates depression and anxiety in young, working women and men.
-
fMRI of alterations in reward selection, anticipation, and feedback in major depressive disorder.
-
miR-149 and miR-29c as candidates for bipolar disorder biomarkers.
-
Keywords of People
-
McClintock, Shawn Michael,
Adjunct Associate Professor in the Department of Psychiatry and Behavioral Sciences,
Psychiatry & Behavioral Sciences, Brain Stimulation and Neurophysiology
-
O'Connor, Christopher Michael,
Richard Sean Stack, M.D. Distinguished Professor,
Medicine, Clinical Pharmacology
-
Olsen, Maren Karine,
Professor of Biostatistics and Bioinformatics,
Biostatistics & Bioinformatics
-
Wu, Li-Tzy,
Professor in Psychiatry and Behavioral Sciences,
Medicine, General Internal Medicine